Sign Up to like & get
recommendations!
0
Published in 2018 at "PET clinics"
DOI: 10.1016/j.cpet.2017.11.011
Abstract: Molecular imaging (mainly PET and MR imaging) has played important roles in gynecologic oncology. Emerging MR-based technologies, including DWI, CEST, DCE-MR imaging, MRS, and DNP, as well as FDG-PET and many novel PET radiotracers, will…
read more here.
Keywords:
oncology emerging;
imaging techniques;
oncology;
emerging molecular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.03.026
Abstract: Cholangiocarcinomas (CCAs) are diverse epithelial tumors arising from the liver or large bile ducts with features of cholangiocyte differentiation. CCAs are classified anatomically into intrahepatic (iCCA), perihilar (pCCA), and distal CCA (dCCA). Each subtype has…
read more here.
Keywords:
molecular therapeutic;
therapeutic targets;
cca;
emerging molecular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Current opinion in lipidology"
DOI: 10.1097/mol.0000000000000463
Abstract: DOI:10.1097/MOL.0000000000000463 Elucidation of the crystal structure of the ATP-binding cassette sub-family G, members 5 and 8 (ABCG5G8) heterodimer responsible for excretion of xenosterols (sterols other than cholesterol) from the liver and into the intestinal lumen…
read more here.
Keywords:
excretion;
molecular clinical;
cholesterol;
xenosterolemia emerging ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24032928
Abstract: The pharmacological treatment of epilepsy is purely symptomatic. Despite many decades of intensive research, causal treatment of this common neurologic disorder is still unavailable. Nevertheless, it is expected that advances in modern neuroscience and molecular…
read more here.
Keywords:
emerging molecular;
molecular targets;
epilepsy modifying;
targets anti ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14061303
Abstract: The constant changes in cancer cell bioenergetics are widely known as metabolic reprogramming. Reprogramming is a process mediated by multiple factors, including oncogenes, growth factors, hypoxia-induced factors, and the loss of suppressor gene function, which…
read more here.
Keywords:
cancer;
cancer cells;
emerging molecular;
metabolic reprogramming ... See more keywords